Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0000899243-21-034306

See Remarks sold 11,000 shares at $27.00 ($297,000)

  • See Remarks acquired 11,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Baeuerle Patrick See Remarks 2021-08-10 Option exercise +11,000 $4.30 $47,300 11,000 D
Baeuerle Patrick See Remarks 2021-08-10 Sale −11,000 $27.00 $297,000 0 D
Derivatives
Baeuerle Patrick See Remarks 2021-08-10 Option exercise · Stock Option (Right to Buy) −11,000 251,114 D
Open-market sales · 11,000 sh · avg $27.00 · $297,000
Loading xslF345X03/doc4.xml…